Peter G Traber insider trades: Selecta Biosciences (SELB) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Peter reports to the SEC
and 1 more company
Open-market buys and sales
22 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Sep 25, 2023 | SELB | ↓ Sell | 705 | $1.06 | $747 | Direct | Sep 26, 2023 (1d) |
| Jan 5, 2023 | SELB | ↓ Sell | 11,644 | $1.13 | $13K | Direct | Jan 6, 2023 (1d) |
| Jan 5, 2022 | SELB | ↓ Sell | 3,226 | $3.09 | $10K | Direct | Jan 7, 2022 (2d) |
| Dec 10, 2021 | SELB | ↓ Sell | 4,083 | $2.99 | $12K | Direct | Dec 14, 2021 (4d) |
| Oct 13, 2021 | SELB | ↓ Sell | 3,636 | $4.39 | $16K | Direct | Oct 15, 2021 (2d) |
| May 26, 2021 | SELB | ↑ Buy | 20,000 | $3.99 | $80K | Direct | May 27, 2021 (1d) |
| May 25, 2021 | SELB | ↑ Buy | 17,500 | $3.37 | $59K | Direct | May 26, 2021 (1d) |
| Mar 18, 2021 | SELB | ↑ Buy | 20,000 | $4.51 | $90K | Direct | Mar 19, 2021 (1d) |
| Dec 14, 2020 | SELB | ↑ Buy | 40,000 | $3.24 | $129K | Direct | Dec 16, 2020 (2d) |
| Jun 13, 2018 | GALT | ↓ Sell | 100,000 | $7.51 | $751K | Direct | Jun 15, 2018 (2d) |
| Jun 8, 2018 | GALT | ↓ Sell | 70,000 | $5.86 | $410K | Direct | Jun 12, 2018 (4d) |
| Aug 12, 2015 | GALT | ↑ Buy | 2,000 | $2.00 | $4K | Direct | Aug 12, 2015 (0d) |
| Jun 1, 2015 | GALT | ↑ Buy | 4,000 | $2.53 | $10K | Direct | Jun 1, 2015 (0d) |
| Aug 14, 2014 | GALT | ↑ Buy | 4,000 | $4.46 | $18K | Direct | Aug 15, 2014 (1d) |
| Aug 13, 2014 | GALT | ↑ Buy | 1,000 | $4.42 | $4K | Direct | Aug 14, 2014 (1d) |
| Dec 9, 2013 | GALT | ↑ Buy | 500 | $8.90 | $4K | Direct | Dec 10, 2013 (1d) |
| Dec 5, 2013 | GALT | ↑ Buy | 500 | $9.00 | $5K | Direct | Dec 5, 2013 (0d) |
| Nov 19, 2013 | GALT | ↑ Buy | 1,000 | $5.53 | $6K | Direct | Nov 19, 2013 (0d) |
| Nov 18, 2013 | GALT | ↑ Buy | 1,000 | $5.80 | $6K | Direct | Nov 19, 2013 (1d) |
| Oct 12, 2012 | GALT | ↑ Buy | 2,500 | $2.11 | $5K | Direct | Oct 15, 2012 (3d) |
| Oct 9, 2012 | GALT | ↑ Buy | 2,500 | $2.00 | $5K | Direct | Oct 10, 2012 (1d) |
| Oct 8, 2012 | GALT | ↑ Buy | 5,000 | $2.07 | $10K | Direct | Oct 9, 2012 (1d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
About Peter G Traber's insider trades
Peter G Traber is Chief Medical Officer at Selecta Biosciences (SELB). Since Oct 8, 2012, Peter has reported 15 open-market purchases worth $436K and 7 sales worth $1.2M on SEC Form 4. There have been no open-market trades in the last 12 months.
Their filings also include grants and awards (32 filings), option exercises (2 filings), other transactions (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every SELB insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.